163 related articles for article (PubMed ID: 24781934)
1. [Importance of Quick, partial thromboplastin time, and Co].
Siegert G
Internist (Berl); 2014 May; 55(5):506, 508, 510-3. PubMed ID: 24781934
[TBL] [Abstract][Full Text] [Related]
2. Coagulation Testing in the Core Laboratory.
Winter WE; Flax SD; Harris NS
Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
[TBL] [Abstract][Full Text] [Related]
3. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
4. [Acquired coagulation disorders].
Suzuki N
Rinsho Ketsueki; 2020; 61(7):779-784. PubMed ID: 32759565
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of coagulation time: PT and APTT].
Ramakers C; van der Heul C; van Wijk EM
Ned Tijdschr Geneeskd; 2012; 156(0):A3985. PubMed ID: 22917038
[TBL] [Abstract][Full Text] [Related]
6. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
Riano I; Prasongdee K
J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
[TBL] [Abstract][Full Text] [Related]
7. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.
Despotis GJ; Santoro SA; Spitznagel E; Kater KM; Barnes P; Cox JL; Lappas DG
Anesthesiology; 1994 Feb; 80(2):338-51. PubMed ID: 8311316
[TBL] [Abstract][Full Text] [Related]
8. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
Murray D; Pennell B; Olson J
Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
[TBL] [Abstract][Full Text] [Related]
9. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
Favaloro EJ; Kershaw G; Mohammed S; Lippi G
Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
[TBL] [Abstract][Full Text] [Related]
10. [Interpretation of hemostatic and fibrinolytic markers].
Asakura H
Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
[TBL] [Abstract][Full Text] [Related]
11. [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].
Zeerleder S; Asmis L; Redondo M; Sulzer I; Lämmle B
Ther Umsch; 1999 Sep; 56(9):509-12. PubMed ID: 10517121
[TBL] [Abstract][Full Text] [Related]
12. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
[TBL] [Abstract][Full Text] [Related]
13. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
14. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
Kamal AH; Tefferi A; Pruthi RK
Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
[TBL] [Abstract][Full Text] [Related]
15. Screening and diagnosis of coagulation disorders.
Lusher JM
Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 2):778-83. PubMed ID: 8828561
[TBL] [Abstract][Full Text] [Related]
16. Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review.
Rasmussen KL; Philips M; Tripodi A; Goetze JP
Eur J Haematol; 2020 Jun; 104(6):519-525. PubMed ID: 32049377
[TBL] [Abstract][Full Text] [Related]
17. A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
Duncan A; Bowie EJ; Owen CA; Fass DN
Clin Chem; 1985 Jun; 31(6):853-5. PubMed ID: 3995763
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
19. Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
Santoro RC; Molinari AC; Leotta M; Martini T
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374373
[TBL] [Abstract][Full Text] [Related]
20. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
Kershaw G; Orellana D
Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]